An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results

dc.authoridViprakasit, Vip/0000-0003-3162-1849
dc.authoridCAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864
dc.authorscopusid7401512064
dc.authorscopusid35433934600
dc.authorscopusid6701871501
dc.authorscopusid7403427269
dc.authorscopusid6602510535
dc.authorscopusid7003851192
dc.authorscopusid6603634753
dc.authorwosidCAPPELLINI, MARIA DOMENICA/B-4475-2017
dc.contributor.authorLai, Yong-Rong
dc.contributor.authorCappellini, Maria Domenica
dc.contributor.authorAydinok, Yesim
dc.contributor.authorPorter, John
dc.contributor.authorKarakas, Zeynep
dc.contributor.authorViprakasit, Vip
dc.contributor.authorSiritanaratkul, Noppadol
dc.date.accessioned2023-01-12T19:49:38Z
dc.date.available2023-01-12T19:49:38Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstract[No Abstract Available]en_US
dc.description.sponsorshipNovartis Pharmaceuticals Corporationen_US
dc.description.sponsorshipThis study was sponsored and funded by Novartis Pharmaceuticals Corporation.en_US
dc.identifier.doi10.1002/ajh.26592
dc.identifier.endpageE284en_US
dc.identifier.issn0361-8609
dc.identifier.issn1096-8652
dc.identifier.issue8en_US
dc.identifier.pmid35560253en_US
dc.identifier.scopus2-s2.0-85130696116en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpageE281en_US
dc.identifier.urihttps://doi.org/10.1002/ajh.26592
dc.identifier.urihttps://hdl.handle.net/11454/75864
dc.identifier.volume97en_US
dc.identifier.wosWOS:000800529100001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofAmerican Journal of Hematologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAn open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year resultsen_US
dc.typeLetteren_US

Dosyalar